Finasteride / dutasteride - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Finasteride, dutasteride – New measures to minimise the risk of suicidal ideation

Key facts

• Active substance:
  • Finasteride
  • dutasteride
• Procedure number:
  EMEA/H/A-31/1539
• Regulatory outcome:
  Variation
• DHPC type:
  Post-authorisation measure
• Dissemination date:
  12/09/2025